Skip to main content
Clinical Trials/NCT03270423
NCT03270423CompletedNot Applicable

PathMate2: The Impact of Health Information System Services on the Effects of Therapy in Overweight Teenagers

Ostschweizer Kinderspital1 site in 1 country40 target enrollmentStarted: January 30, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
40
Locations
1
Primary Endpoint
Body Mass Index

Study Overview

Brief Summary

Randomised controlled trial in overweight adolescents using a health App.

Detailed Description

Problem In Switzerland, 20% of children are overweight and novel methods are urgently needed to control the epidemic. Foundations of chronic diseases develop during childhood and track into adulthood obesity in more than 75% of patients, contributing to a significant increase in public health costs.

Multi-professional programs combining physical activity, nutritional and behavioral components have positive effects on therapy outcomes and co-morbidities, but these interventions induce high costs and are time-consuming for health providers, patients and families, in particular those living in rural regions. In fact, less than 0.2% of overweight children can participate in these programs. Thus, health information systems (HIS) have not only the potential to improve outcomes of obesity therapy but also to reduce health costs and increase access to health care in remote regions. Most HIS have indeed not been evaluated in this regard.

Preparation work In the PathMate project (SNF grant #135552), a mobile HIS has been developed for teenagers to support therapy and to prevent obesity in accordance with state-of-the-art multiprofessional programs and, in contrast to commercially available IT applications, with a high standard of data protection and safety. The IS effects of this HIS have been successfully evaluated in first longitudinal studies. In parallel, the impact of multi-professional therapies in Swiss children as well as potential confounders have been established in several longitudinal cohort studies with up to two-years follow-up.

Objectives

The overall goal of PathMate2 is to assess the impact of HIS services on the degree of obesity measured by the body mass index (BMI) incl. other health outcomes. Individual and shared understanding between patients and therapists are assessed as mediating factors. Specific goals are:

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
11 Years to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •obesity, BMI > P. 97 (Jenni et al., 2011) or overweight, BMI >P.90, plus risk factors or co-morbidity
  • •ability and parent's permission to use pre-configured study smartphones handed out to the children
  • •readiness to use the personal smartphone number and to spend the sum allocated exclusively for the study SMS during the 6 months of intervention

Exclusion Criteria

  • •major somatic or psychiatric disease without adequate treatment,
  • •weight-relevant medication (antiepileptic drugs, methylphenhydate and similar medication),
  • •inability or lack of parent's or caregivers' permission to use a study smartphone with a mobile phone contract,
  • •lack of informed consent from children and parents and
  • •undue consumption of the amount allocated for study SMS for non-study purposes,
  • •overuse of smartphone e.g. without night beak for at least 8 hours.

Arms & Interventions

Control SG

No Intervention

Therapy during 6 months with usual care. 10 therapy visits over 6 months

Intervention SG

Active Comparator

Therapy during 6 months with PathMate2 design. 6 therapy visits + PathMate2 over 6 months

Intervention: PathMate2 (Device)

Intervention VD

Active Comparator

Adapted sport session 1h/week + PathMate-S during 6 months

Intervention: PathMateS (Device)

Control VD

No Intervention

Adapted sport session 1h/week during 6 months

Outcomes

Primary Outcomes

Body Mass Index

Time Frame: 12 months

Main outcome parameter is Body Mass Index, as BMI-SDS adjusted for gender \& age. Group size of 4\*20 was based on an expected decrease by -0.23±0.02 (SDS, Mean±SD) after 1 year, from initially 2.88±0.7.

Secondary Outcomes

  • stress and arousal(12 months)
  • stress and arousal, biophysical measure(12 months)
  • well-being(12 months)
  • waist circumference(12 months)
  • fitness / physical activity(12 months)
  • stress reduction, biological measure(12 months)
  • reduction of chronic stress(12 months)
  • fitness / physical capability(12 months)

Investigators

Sponsor
Ostschweizer Kinderspital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dagmar l'Allemand

Prof. Dr. med.

Ostschweizer Kinderspital

Study Sites (1)

Loading locations...

Similar Trials

PathMate2: The Impact of Health... | Clinical Trial